Stockscreener 앱 받기
4.44
4.10%
-0.19
시간 외 거래:
4.39
-0.05
-1.13%
전일 마감가:
$4.63
열려 있는:
$4.68
하루 거래량:
5.19M
Relative Volume:
1.19
시가총액:
$1.00B
수익:
-
순이익/손실:
$-283.26M
주가수익비율:
-3.0204
EPS:
-1.47
순현금흐름:
$-273.61M
1주 성능:
+5.21%
1개월 성능:
+70.11%
6개월 성능:
+52.05%
1년 성능:
-23.45%
1일 변동 폭
$4.165
$4.80
1주일 범위
$4.09
$4.80
52주 변동 폭
$1.26
$7.30
사나 바이오테크놀로지 Stock (SANA) Company Profile
명칭
Sana Biotechnology Inc
전화
(206) 701-7914
주소
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
4.44 | 951.84M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
사나 바이오테크놀로지 Stock (SANA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-03-18 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 개시 | Jefferies | Buy |
| 2025-01-08 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-11-05 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 개시 | Rodman & Renshaw | Buy |
| 2024-01-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-05 | 개시 | Citigroup | Buy |
| 2023-08-14 | 개시 | TD Cowen | Market Perform |
| 2023-05-02 | 개시 | H.C. Wainwright | Neutral |
| 2021-03-01 | 개시 | BofA Securities | Buy |
| 2021-03-01 | 개시 | Goldman | Neutral |
| 2021-03-01 | 개시 | JP Morgan | Neutral |
| 2021-03-01 | 개시 | Morgan Stanley | Overweight |
모두보기
사나 바이오테크놀로지 주식(SANA)의 최신 뉴스
Commit To Purchase Sana Biotechnology At $2.50, Earn 28% Using Options - Nasdaq
What analysts say about Sana Biotechnology Inc. stockExtraordinary earning power - Autocar Professional
Is Sana Biotechnology Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com
Sana Biotechnology Inc. Stock Analysis and ForecastExponentially increasing returns - jammulinksnews.com
What drives Sana Biotechnology Inc. stock priceMassive profits - jammulinksnews.com
Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors - GlobeNewswire Inc.
How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes - Benzinga
Sana Biotechnology, Inc. (SANA) Secures an Overweight Rating from Morgan Stanley - MSN
Sana Reports Promising Diabetes Cell Therapy Data at ADA Meeting - MSN
Sana Biotechnology’s SWOT analysis: innovative cell therapy stock faces challenges By Investing.com - Investing.com South Africa
Sana Biotechnology’s SWOT analysis: innovative cell therapy stock faces challenges - Investing.com
Sana Biotechnology's 9% Spike: Technical Signals and Peer Dynamics Drive Unusual Intraday Rally - AInvest
Sana Biotechnology (SANA.O) Surges 9% Amid Technical Bullish Signal: What’s Driving the Move? - AInvest
Sana Biotechnology's 9% Surge: Technical Bullishness or Biotech Momentum? - AInvest
Sana Biotechnology's 9% Surge: Technical Bullish Signal or Sector Shift? - AInvest
Sana Biotechnology’s 9% Surge: Technical Catalysts and Peer Dynamics - AInvest
Sana Biotechnology's 9% Surge: Technicals or a Hidden Catalyst? - AInvest
Sana Biotechnology's 9% Spike: A Technical Catalyst Amid Mixed Biotech Sentiment - AInvest
Sana Biotechnology's 9% Surge: Technical Catalysts and Market Dynamics - AInvest
Sana Biotechnology assumed with an Overweight at Morgan Stanley - TipRanks
Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results - MSN
Top 10 CRISPR Stocks to Buy Now - Insider Monkey
Sana Biotechnology, Inc.(NasdaqGS: SANA) added to Russell 3000E Value Index - MarketScreener
Sana Biotechnology (SANA) Receives a Buy from Citizens JMP - The Globe and Mail
BofA Remains Bullish on Sana Biotechnology (SANA) - MSN
Sana Biotechnology Reports Promising Six-Month Results from First-in-Human Study on Hypoimmune-Modified Pancreatic Islet Cell Transplant for Type 1 Diabetes - Nasdaq
SANA Stock on the Rise: A Promising Investment - investchronicle.com
Investigation announced for long-term Investors in shares - openPR.com
Pallas Capital Advisors LLC Makes New $29,000 Investment in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology (NASDAQ:SANA) versus Mosaic ImmunoEngineering (OTCMKTS:CPMV) Critical Analysis - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 25,383 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Lead Plaintiff Appointed in Sana Biotechnology Class Action — Here’s How You Can Recover Your Losses - TradingView
Paysign Leads Our Trio Of Penny Stock Highlights - simplywall.st
Transcript : Sana Biotechnology, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener
Sana Biotechnology to present at 85th annual American Diabetes Association Scientific Sessions - marketscreener.com
Sana Biotechnology to Present First-in-Human Clinical Data on Hypoimmune Islet Cell Therapy for Type 1 Diabetes at ADA Scientific Sessions - Nasdaq
Sana Biotechnology Announces Invited Oral Presentation at - GlobeNewswire
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes ... - Bluefield Daily Telegraph
Sana Bio to Present Novel Immunosuppression-Free Diabetes Cell Therapy Data at ADA | SANA Stock News - Stock Titan
Shareholders Filed a Lawsuit Against $SANA for Misleading Investors About Financial Health - TradingView
Two Sigma Investments LP Grows Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Ameriprise Financial Inc. Invests $29,000 in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Squarepoint Ops LLC Buys 55,625 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology Elects Directors at Annual Meeting - TipRanks
Transcript : Sana Biotechnology, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 02 - MarketScreener
Sana Biotechnology, Inc. (NASDAQ:SANA) Stock Position Raised by Two Sigma Advisers LP - Defense World
Nuveen Asset Management LLC Sells 27,104 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Biggest Stocks in NASDAQ Featuring Sana Biotechnology and Kalkine - Kalkine Media
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Millennium Management LLC - Defense World
사나 바이오테크놀로지 (SANA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):